Stock Price
11.14
Daily Change
-0.14 -1.24%
Monthly
-6.39%
Yearly
13.06%
Q2 Forecast
9.45

Immunic reported $24.05M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
BioMarin Pharmaceutical USD 8.59B 996.99M Mar/2026
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Enanta Pharmaceuticals USD 329.5M 48.77M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 24.05M 16.65M Dec/2025
Insmed USD 2.26B 96.18M Dec/2025
Omeros USD 200.57M 34.59M Jun/2025
OraSure Technologies USD 403.17M 19.93M Dec/2025
Quidel USD 5.63B 140.6M Mar/2026
Ultragenyx Pharmaceutical USD 1.3B 236M Mar/2026
United Therapeutics USD 6.71B 1.17B Mar/2026
Xoma USD 263.15M 39.7M Sep/2025